Evidence map›Paper›PMID 37165197›Full record

ArticleScientific reports2023

PeruNPDB: the Peruvian Natural Products Database for in silico drug screening.

Haruna L Barazorda-Ccahuana, Lena Gálvez Ranilla, Mayron Antonio Candia-Puma, Eymi Gladys Cárcamo-Rodriguez, Angela Emperatriz Centeno-Lopez, Gonzalo Davila-Del-Carpio, José L Medina-Franco, Miguel Angel Chávez-Fumagalli

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Latin American Natural Product Database (LANaPDB): An Update.Journal of chemical information and modeling · 2024
    Article
  8. Chemical Multiverse and Diversity of Food Chemicals.Journal of chemical information and modeling · 2024
    Article
  9. TargetingFrontiers in pharmacology · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Computational Exploration ofBioinformatics and biology insights · 2024
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Haruna L Barazorda-CcahuanaComputational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, 04000, Arequipa, Peru.
Lena Gálvez RanillaLaboratory of Research in Food Science, Universidad Catolica de Santa Maria, 04000, Arequipa, Peru.
Mayron Antonio Candia-PumaComputational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, 04000, Arequipa, Peru.
Eymi Gladys Cárcamo-RodriguezComputational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, 04000, Arequipa, Peru.
Angela Emperatriz Centeno-LopezComputational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, 04000, Arequipa, Peru.
Gonzalo Davila-Del-CarpioFacultad de Ciencias Farmacéuticas, Bioquímicas y Biotecnológicas, Universidad Católica de Santa María, 04000, Arequipa, Peru.
José L Medina-FrancoDIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, 04510, Mexico City, Mexico.
Miguel Angel Chávez-FumagalliComputational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, 04000, Arequipa, Peru. mchavezf@ucsm.edu.pe.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the number of drugs based on natural products (NPs) represents a large source of novel pharmacological entities, NPs have acquired significance in drug discovery. Peru is considered a megadiverse country with many endemic species of plants, terrestrial, and marine animals, and microorganisms. NPs databases have a major impact on drug discovery development. For this reason, several countries such as Mexico, Brazil, India, and China have initiatives to assemble and maintain NPs databases that are representative of their diversity and ethnopharmacological usage. We describe the assembly, curation, and chemoinformatic evaluation of the content and coverage in chemical space, as well as the physicochemical attributes and chemical diversity of the initial version of the Peruvian Natural Products Database (PeruNPDB), which contains 280 natural products. Access to PeruNPDB is available for free ( https://perunpdb.com.pe/ ). The PeruNPDB's collection is intended to be used in a variety of tasks, such as virtual screening campaigns against various disease targets or biological endpoints. This emphasizes the significance of biodiversity protection both directly and indirectly on human health.

Indexed as

Biological ProductsAnimalsDatabases, FactualDrug DiscoveryDrug Evaluation, PreclinicalHumansPeruBiological Products

Identifiers

PMID37165197
PMCPMC10170056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.